Status and phase
Conditions
Treatments
About
This pilot clinical trial will evaluate the initial safety and feasibility of microbiota transplant therapy (MTT) inpatients with primary sclerosing cholangitis (PSC). This trial will inform development of future trials in treatment of PSC.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
28 participants in 1 patient group
Loading...
Central trial contact
Amanda Kabage
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal